LFF-571

Star0

DB13013InvestigationalSmall molecule

LFF571 has been used in trials studying the treatment of Moderate Clostridium Difficile Infection.

Formula / weight: C₆₀H₆₃N₁₃O₁₃S₆ · 1366.6 g/mol (avg)
Code names: J3.333.591A · LFF571

Resolves to

Compound

UNIIW7AUL2R95ZCAS1160959-55-6ChEMBLCHEMBL2063705PubChem42638236

Structure

InChIKeyGNLYKLDXQZHYTR-LMOGNUDZSA-NSMILES

CNC(=O)C[C@@H]1NC(=O)C2=CSC(=N2)C2=CC=C(N=C2C2=CSC(=N2)C2=CSC(=N2)[C@@H](NC(=O)CNC(=O)C2=C(COC)SC(=N2)[C@@H](NC(=O)C2=C(C)SC1=N2)C(C)C)[C@@H](O)C1=CC=CC=C1)C1=NC(=CS1)N(CCCCC(O)=O)C(=O)O[C@H]1CC[C@@H](CC1)C(O)=O

What you can answer from here — as of June 12, 2020

1Clinical trialPhase, status and sponsor resolved per trial

Which companies are running trials of LFF-571, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account